Navigation Links
OmniPod(R) Insulin Management System Wins 2009 Edison Best New Product Award
Date:4/1/2009

Recognized for Innovative Design, Positive Impact on Lives of People with Insulin-Dependent Diabetes

BEDFORD, Mass., April 1 /PRNewswire-FirstCall/ -- The OmniPod(R) Insulin Management System, designed and produced by Insulet Corporation (Nasdaq: PODD), today won a 2009 Edison Best New Product Award(TM). The product was honored with the Gold Award in the Science and Medical category in recognition of its innovative design that offers people living with insulin-dependent diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes.

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod -- a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager -- a wireless, menu-driven, hand-held device that programs the Pod.

OmniPod user Ethan Alexander of San Francisco, who attended the awards ceremony held in Mountain View, CA, is one such person who benefits from the product's unique features. He was diagnosed with type 1 diabetes in 1999 and initially used conventional insulin pumps to deliver his insulin. "Those pumps weren't right for me because I have an active life that includes surfing and playing soccer," Mr. Alexander said. "The tubing frequently got in the way, keeping me from doing what I wanted."

"OmniPod lets me live my life my way and is the best choice for me. I now can freely engage in all these activities while receiving my insulin, because it has no tubing, is watertight, durable and is always on me. As
'/>"/>

SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
2. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
3. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
4. NICE SUGAR: Intensive insulin therapy risks
5. Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan
6. Gene Explains How High-Fructose Diets Lead to Insulin Resistance
7. Ethnicity May Drive Response to Obesity, Insulin Resistance
8. Fasting Signal Offers Clues to Insulin Resistance in the Obese
9. Insulin drug study shows significant improvements in more than 52,000 diabetic patients
10. Ethnic differences found for fatty liver disease and insulin resistance
11. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Quincy Bioscience, makers ... is pleased to announce the release of the fourth ... president and co-founder Mark Underwood. , The Brain Health ... offering useful techniques for readers to improve memory and ... unavoidable conclusion, The Brain Health Guide provides ways to ...
(Date:7/28/2014)... procedure to treat severe chronic migraine headaches led to ... time in patients treated at Massachusetts General Hospital (MGH). ... Reconstructive Surgery report that more than half of 35 ... whom had headaches associated with compression of craniofacial nerves ... The team,s paper has received advance online publication in ...
(Date:7/28/2014)... Massachusetts (PRWEB) July 28, 2014 ... Summit Provider Exchange technology solution in ... integration efforts and support collaboration with their New ... bed acute-care medical center located in New Jersey, ... seasonal visitors with a variety of inpatient and ...
(Date:7/28/2014)... runners are far more likely to die of heat ... new study. The researchers pointed out that ... actually 10 times more likely to develop severe and ... of a young and apparently healthy person due to ... gets a lot more media attention. "This research ...
(Date:7/28/2014)... The Oakwood Foundation celebrated a major gift this ... PC that will benefit each community we serve for ... The HBWS group is among the Foundation’s largest physician ... donations. Through their latest gift, they will be one ... Classic for the next 6 years; provide state-of-the-art technology ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2
... flawless video transmission will enable advances in telemedicine ... and the digital marketplace, board members say, ... enables medical, government and media customers to flawlessly,transport high-bandwidth, ... the formation of the Rivulet,Technical Advisory Board and the ...
... coalition calls for quality standards to protect Pennsylvania ... families from inadequate regulations, ... facilities to rent rooms to residents that,do not meet current ... or walkers., While new assisted living construction would be ...
... Harvard Initiative for Global Health (HIGH) has been selected ... Health grant from the National Institutes of Health,s Fogarty ... by an additional $300,000 grant from the University and ... global heath. The grant will fund the Fostering Opportunities ...
... her boyfriend, a 35-year-old woman suddenly felt her left arm ... on the left side of her face. , She was ... due to several related factors, including birth control pills, a ... , Doctors at Loyola University Medical Center describe the ...
... WALNUT CREEK, Calif., Sept. 14 Longs Drug,Stores ... that it had,received an unsolicited, non-binding expression of ... offer of $75.00 per share in cash,for all ... diligence and,negotiating a definitive agreement. Longs, Board of ...
... amplified in these malignancies, study finds , , SUNDAY, ... new genetic player in the development of colon cancer. ... gene expression in the proliferation of colorectal cancer, the ... could lead to new therapeutic approaches for colon cancer, ...
Cached Medicine News:Health News:Rivulet Communications Announces New Technical Advisory Board and Initial Board Appointments 2Health News:Rivulet Communications Announces New Technical Advisory Board and Initial Board Appointments 3Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 2Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 3Health News:Harvard University recipient of Global Health Nutrition grant 2Health News:Unusual case of a woman who suffered stroke during sex 2Health News:Unusual case of a woman who suffered stroke during sex 3Health News:Longs Drug Stores Confirms Receipt of Expression of Interest from Walgreens 2Health News:Longs Drug Stores Confirms Receipt of Expression of Interest from Walgreens 3Health News:Colon Cancer Oncogene Discovered 2Health News:Colon Cancer Oncogene Discovered 3
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China , today announced that ... a special cash dividend of US$0.30 per ordinary share ... Company,s outstanding ordinary shares. The total expense for the ...
(Date:7/28/2014)... , July 28, 2014 ... Ventures 2,5 Millionen £ investiert hat, um ... Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche zu erfüllen. ...      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ) ... hat OmPrompt sein beschleunigtes Wachstum mit Investitionen ...
(Date:7/28/2014)... and NEW PROVIDENCE, N.J. ... engineering professionals are invited to meet with Linde,s Healthcare ... Technical Exhibition to be held at McCormick Place in ... "Hospitals demand nothing less than complete ... Mark Sanda , Linde,s Healthcare Segment manager. "Linde understands ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... BETHESDA, Md., Dec. 19, 2011 /PRNewswire-Asia/ -- Chindex International, ... care company providing health care services in China through ... private primary care hospitals and affiliated ambulatory clinics, today ... Hospital ("TJU"), one of the latest development projects of ...
...   , First once-daily, fixed-dose preventative treatment ... heartbeat) at risk of the devastating consequences of stroke ... solution for the treatment of deep vein thrombosis (DVT) ... is now approved in the UK for the prevention ...
Cached Medicine Technology:Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 2Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 3Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 2Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 3Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 5Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: